Cryoport Chain of Compliance®

In the near future, Regenerative Medicine will be the standard of care for currently intractable diseases. These new therapies are very fragile, and a single temperature fluctuation will destroy the product. We have created a standard of distribution, called Chain of Compliance®, which establishes full traceability of equipment and processes used in managing the distribution of these therapies.